Aisling Capital Management LP
aislingcapital.com Direct investor
Aisling Capital is an investment firm that invests in healthcare products, technologies, and services. It manages over $1.8 billion in committed capital across multiple funds and invests in both private and public companies.
Aisling Capital Management LP is a venture capital firm headquartered in New York, United States, founded in 2000. It invests directly in companies, from seed to growth, in healthcare, biopharma, medical device and services. $1.8 billion under management, as it reports.
“Aisling Capital is a leading investment firm that invests in products, technologies, and global businesses that advance health.”
— Aisling Capital Management LP, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- New York, United States
- Invests in
- US
- Sectors
- healthcare, biopharma, medical device, services
- Founded
- 2000
- Assets under management
- $1.8 billion
Team, as Aisling Capital Management LP publishes it
- Steven Elms Managing Partner
- Andrew Schiff, MD Managing Partner
- Eric Aguiar, MD Partner
- Sunny Reddy Principal
- Wonpyo Yun Principal
- Robert Wenzel Chief Financial Officer and Chief Compliance Officer
- Katie Tansey Vice President of Investor Relations and Marketing
- Hannah Wieder Controller
- Carol Zikopoulos Head of Human Resources and Compliance Manager
- Dr. Josh Bilenker Operating Partner
- Scott Braunstein, MD Operating Partner
Names and roles exactly as listed on aislingcapital.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 71 co-investors found.
- Foresite Capital 9 shared companies: ascendispharma.com, aclaristx.com, bicara.com, pfizer.com…
- Hercules Adviser LLC 9 shared companies: bridgebio.com, agiletherapeutics.com, compasspathways.com, admabiologics.com…
- EcoR1 Capital 8 shared companies: scholarrock.com, arcusbio.com, bridgebio.com, nabriva.com…
- RA Capital Management 6 shared companies: ascendispharma.com, forgebiologics.com, aclaristx.com, bicara.com…
- Frazier Life Sciences Management, LP 6 shared companies: veronapharma.com, bridgebio.com, chimerix.com, gondolabio.com…
- Sofinnova Investments, INC. 5 shared companies: ascendispharma.com, obseva.com, aclaristx.com, audentestx.com…
- F-Prime Capital 5 shared companies: allergan.com, aclaristx.com, bicara.com, sanofi.us…
- Avoro Capital Advisors LLC 4 shared companies: ascendispharma.com, syndax.com, gbt.com, monterosatx.com
- Sofinnova 4 shared companies: ascendispharma.com, f2g.com, obseva.com, veronapharma.com
- ARCH Venture Partners 4 shared companies: scholarrock.com, syros.com, allergan.com, treeline.bio
and 61 more — the graph.
Where this comes from
Every fact above was read from a page Aisling Capital Management LP publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.aislingcapital.com/name, is_investor, hq_country, hq_city, sectors, description, aum, status, confidence
- https://www.aislingcapital.com/aboutlayer, type, stage_min, stage_max, thesis_quote, thesis_quote_page, founded
- https://www.aislingcapital.com/portfolioinvests_in_geographies
- https://www.aislingcapital.com/teampeople
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 5777 · added 2026-09-03 · link last verified 2026-09-06 · confidence high
Similar investors
- Decheng CapitalVenture capital · Seed – Growth · Menlo Park, United States
- NGN Capital LLCVenture capital · Seed – Series B · New York, United States
- 2048 VenturesVenture capital · Pre-seed – Seed · New York, United States
- AlleyCorpVenture capital · Pre-seed – Series A · New York, United States
- Alta PartnersVenture capital · San Francisco, United States
- Avid VenturesVenture capital · Pre-seed – Series A · New York, United States